These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37236514)

  • 1. The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence.
    Al-Haideri MT; Mannani R; Kaboli R; Gharebakhshi F; Darvishzadehdeldari S; Tahmasebi S; Faramarzi F; Cotrina-Aliaga JC; Khorasani S; Alimohammadi M; Darvishi M; Akhavan-Sigari R
    Transpl Immunol; 2023 Aug; 79():101858. PubMed ID: 37236514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease.
    Haberman RH; Herati RS; Simon D; Samanovic M; Blank RB; Tuen M; Koralov SB; Atreya R; Tascilar K; Allen JR; Castillo R; Cornelius AR; Rackoff P; Solomon G; Adhikari S; Azar N; Rosenthal P; Izmirly P; Samuels J; Golden B; Reddy S; Neurath M; Abramson SB; Schett G; Mulligan MJ; Scher JU
    medRxiv; 2021 May; ():. PubMed ID: 34013285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review.
    Gisondi P; Simon D; Alarcon I; Pournara E; Puig L
    J Dermatolog Treat; 2023 Dec; 34(1):2167487. PubMed ID: 36625506
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID.
    Kummer LYL; Fernández Blanco L; Kreher C; Bos A; Kuijper LH; Verstegen NJM; van de Sandt CE; Konijn VAL; Duurland MC; Menage C; Jorritsma T; Steenhuis M; Hagen RR; van den Dijssel J; de Jongh R; Ashhurst T; van Gils MJ; Garcia-Vallejo JJ; Claireaux M; Stalman EW; van Dam KPJ; Wieske L; Boekel L; Wolbink G; Tas SW; Rispens T; Kuijpers TW; Eftimov F; van Ham SM; Ten Brinke A;
    RMD Open; 2024 Oct; 10(4):. PubMed ID: 39375177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.
    Haberman RH; Herati R; Simon D; Samanovic M; Blank RB; Tuen M; Koralov SB; Atreya R; Tascilar K; Allen JR; Castillo R; Cornelius AR; Rackoff P; Solomon G; Adhikari S; Azar N; Rosenthal P; Izmirly P; Samuels J; Golden B; Reddy SM; Neurath MF; Abramson SB; Schett G; Mulligan MJ; Scher JU
    Ann Rheum Dis; 2021 Oct; 80(10):1339-1344. PubMed ID: 34035003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
    Arumahandi de Silva AN; Frommert LM; Albach FN; Klotsche J; Scholz V; Jeworowski LM; Schwarz T; Ten Hagen A; Zernicke J; Corman VM; Drosten C; Burmester GR; Biesen R
    Ann Rheum Dis; 2022 Jun; 81(6):881-888. PubMed ID: 35288376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial.
    Araujo CSR; Medeiros-Ribeiro AC; Saad CGS; Bonfiglioli KR; Domiciano DS; Shimabuco AY; Silva MSR; Yuki EFN; Pasoto SG; Pedrosa T; Kupa LVK; Zou G; Pereira RMR; Silva CA; Aikawa NE; Bonfa E
    Ann Rheum Dis; 2022 Jun; 81(6):889-897. PubMed ID: 35193873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    Cheung MW; Dayam RM; Shapiro JR; Law JC; Chao GYC; Pereira D; Goetgebuer RL; Croitoru D; Stempak JM; Acheampong L; Rizwan S; Lee JD; Jacob L; Ganatra D; Law R; Rodriguez-Castellanos VE; Kern-Smith M; Delgado-Brand M; Mailhot G; Haroon N; Inman RD; Piguet V; Chandran V; Silverberg MS; Watts TH; Gingras AC
    J Immunol; 2023 Aug; 211(3):351-364. PubMed ID: 37326480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases.
    Sieiro Santos C; Calleja Antolin S; Moriano Morales C; Garcia Herrero J; Diez Alvarez E; Ramos Ortega F; Ruiz de Morales JG
    RMD Open; 2022 Jan; 8(1):. PubMed ID: 34987093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
    Al-Janabi A; Ra A; Littlewood Z; Foulkes AC; Hunter HJA; Chinoy H; Moriarty CA; Hyrich KL; Limdi JK; Yiu ZZN; Griffiths CEM; Warren RB
    Br J Dermatol; 2023 Mar; 188(4):542-551. PubMed ID: 36695406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination.
    Andreica I; Blazquez-Navarro A; Sokolar J; Anft M; Kiltz U; Pfaender S; Vidal Blanco E; Westhoff T; Babel N; Stervbo U; Baraliakos X
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36104115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID study.
    Geldof J; Truyens M; Sabino J; Ferrante M; Lambert J; Lapeere H; Hillary T; Van Laethem A; de Vlam K; Verschueren P; Padalko E; Lobaton T; Vermeire S
    Front Immunol; 2023; 14():1126351. PubMed ID: 36936974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study.
    Hitchon CA; Mesa C; Bernstein CN; Marrie RA; Card C; O'Brien SF; Kim J
    BMJ Open; 2023 May; 13(5):e071397. PubMed ID: 37253487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.
    Firinu D; Perra A; Campagna M; Littera R; Fenu G; Meloni F; Cipri S; Sedda F; Conti M; Miglianti M; Costanzo G; Secci M; Usai G; Carta MG; Cappai R; Orrù G; Del Giacco S; Coghe F; Chessa L
    Clin Exp Med; 2022 Aug; 22(3):477-485. PubMed ID: 34741188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.
    Mahil SK; Bechman K; Raharja A; Domingo-Vila C; Baudry D; Brown MA; Cope AP; Dasandi T; Graham C; Khan H; Lechmere T; Malim MH; Meynell F; Pollock E; Sychowska K; Barker JN; Norton S; Galloway JB; Doores KJ; Tree T; Smith CH
    Lancet Rheumatol; 2022 Jan; 4(1):e42-e52. PubMed ID: 34778846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis.
    Stahl D; Tho Pesch C; Brück C; Esser RL; Thiele J; Di Cristanziano V; Kofler DM
    RMD Open; 2022 Oct; 8(2):. PubMed ID: 36216409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
    Simon D; Tascilar K; Fagni F; Krönke G; Kleyer A; Meder C; Atreya R; Leppkes M; Kremer AE; Ramming A; Pachowsky ML; Schuch F; Ronneberger M; Kleinert S; Hueber AJ; Manger K; Manger B; Berking C; Sticherling M; Neurath MF; Schett G
    Ann Rheum Dis; 2021 Oct; 80(10):1312-1316. PubMed ID: 33958324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis.
    Feuchtenberger M; Kovacs MS; Eder A; Nigg A; Schäfer A
    Rheumatol Int; 2022 Jun; 42(6):959-966. PubMed ID: 35429290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.